Resistance to the proapoptotic effects of interferon-gamma on melanoma cells used in patient-specific dendritic cell immunotherapy is associated with improved overall survival.
Okt 2010 - :1432-0851 [PMID:20960187]
[Cornforth AN] [Fowler AW] [Carbonell DJ] [Dillman RO]

Increases in serum TARC/CCL17 levels are associated with progression-free survival in advanced melanoma patients in response to dendritic cell-based immunotherapy.
Aug 2009 - J. Clin. Immunol.; 29(5):1573-2592 [PMID:19421847]
[Cornforth AN] [Lee GJ] [Fowler AW] [Carbonell DJ] [Dillman RO]